SLATTERY JOSEPH P sold $113K of REPL
SLATTERY JOSEPH P sold 5,200 shares of Replimune Group, Inc. (REPL) at $21.80 ($0.11M total) on 2026-11-09.
How this was made
The 30-second read
Why it matters
A director's sale of $113K is modest but may attract short‑term attention.
Market read
The filing provides a fresh, primary‑source data point but its small scale limits trading relevance.
What to watch
The director may be diversifying holdings; no change in company fundamentals.
Background
SEC Form 4 filing discloses insider transactions; investors monitor these for signals.
Ticker impact
Director Joseph Slattery sold 5,200 shares for $113,360, reducing his stake to 1,467 shares.
likely slight pressure as the market prices in the director's sell.
A director's open‑market sale, though modest in size, can be interpreted as a lack of confidence and may prompt short‑term selling.
Market effects
Minimal impact on the biotech sector; the sale is company‑specific.
None
None
Counterpoint
The sale could be routine portfolio rebalancing rather than a negative signal.
Key entities
- CompanyReplimune Group, Inc.
Biotech firm listed on NASDAQ under ticker REPL.
- IndividualJoseph Slattery
Director of Replimune Group, Inc.


